Cornea - MD Browse

Cornea

Speciality
Spotlight

Clinical Pharmacology

Cornea

S. Tyring, R Engst, et al (Collaborative Famciclovir Ophthalmic Zoster Research Group)

Famciclovir for ophthalmic zoster: a randomized aciclovir controlled study.

Br.J.Ophthal, May 2001; 85: 576-581.



Famciclovir 500mg three times daily was well tolerated and demonstrated efficacy similar to aciclovir 800mg five times daily.



Apart from a more convenient dose regimen, this study found no significant advantage of famciclovir over
acyclovir.

Speciality Spotlight

Clinical Pharmacology

Cornea

S. Tyring, R Engst, et al (Collaborative Famciclovir Ophthalmic Zoster Research Group)
Famciclovir for ophthalmic zoster: a randomized aciclovir controlled study.
Br.J.Ophthal, May 2001; 85: 576-581.

Famciclovir 500mg three times daily was well tolerated and demonstrated efficacy similar to aciclovir 800mg five times daily.

Apart from a more convenient dose regimen, this study found no significant advantage of famciclovir over acyclovir.

By Oleg Iuchis|2022-07-20T16:42:17+00:00July 20, 2022|Uncategorized|Comments Off

About the Author: Oleg Iuchis

It is a long established fact that the read will been distracted by there readable an important content. It is a long established fact that the read will been distracted.

It is a long established fact that the read will been distracted by there readable an important content. It is a long established fact that the read will been distracted.